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Abstract
Background While bariatric surgery is an effective therapy for patients with severe obesity, not all patients benefit equally. An
explanation might be that psychosocial risk factors hamper outcome. The study aimed to evaluate if biopsychosocial case
complexity predicts evolution of BMI over 10 years after bariatric surgery.
Methods Charts of patients (N = 236) of the Cohort of Obesity Lausanne (COOL) were retrospectively reviewed and rated with
the INTERMED, a reliable and validated instrument, which assesses biopsychosocial case complexity and has been proven to
predict outcome of medical treatments in different patient populations. The sample was stratified into BMI quartiles, computed
from the patients’ baseline BMI. For each quartile, BMI evolution was analyzed using individual growth curve analysis.
Results Growth curve analyses showed that in quartiles 1, 2, and 3, none of the INTERMED domain scores significantly
predicted the BMI evolution after surgery. However, in the fourth quartile—including patients with the highest pre-surgical
BMI—the social domain score of the INTERMED significantly predicted BMI evolution: patients with more social complexity
showed higher increase in BMI.
Conclusion Effectiveness of interventions targeted at social complexity, especially when patients suffer from severe obesity, may
therefore be evaluated in future studies.
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Introduction
Obesity, defined as excessive fat accumulation that may im-
pair health, concerns 650 million of adult aged 18 years and
over [1]. Obesity has nearly tripled in many European coun-
tries since the 1980s [2], and its progression continues.
Treatments for obesity include lifestyle interventions, pharma-
cotherapy, and bariatric surgery [3]. Many individuals strug-
gle to maintain weight loss with lifestyle interventions, and
although the landscape of obesity pharmacotherapies is rapid-
ly changing, the long-term results of treatments like GLP-1
analogs has yet to be demonstrated [4, 5]. On the other hand,
bariatric surgery achieves sustained reduction in weight, im-
provement of co-morbidities, and prolonged survival [6]. The
Roux-en-Y gastric bypass (RYGBP) and the sleeve gastrecto-
my are currently the most commonly performed operations
worldwide and considered by many clinicians and researchers
as gold standard. Cohorts—such as the Cohort of Obesity
Lausanne (COOL)—have thus been created to investigate
Key Points
• Bariatric surgery patients show high levels of psychosocial case
complexity.
• Social comorbidity predicts BMI evolution after bariatric surgery.
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long-term effects of surgery [7]. Even though the majority of
patients seem to benefit from bariatric surgery, not all benefit
equally. However, it remains impossible to identify patients
who will show insufficient weight loss or important weight
regain after surgery [8]; this subgroup with a diminished
response—defined as less than 20% of weight loss—
concerns 19 to 35% of patients 10 years after surgery
(RYGBP) [9–11].
Both, biological and psychosocial factors might explain
diminished treatment response in patients who undergo obe-
sity surgery. However, evidence-based psychosocial outcome
prediction of obese patients who undergo surgery is lacking
[11, 12].
The aim of the present study was to evaluate if the
INTERMED—a biopsychosocial instrument to assess case
complexity and to identify patients with poor response tomed-
ical treatments [13]—also predicts less favorable outcome in
the long term after RYGB.
Methods
Study Design and Participants
Participants were recruited from the COOL, which was initi-
ated inMarch 2015 (including a retrospective arm since 1999)
with the aim to investigate long-term evolution after bariatric
surgery and to determine prognostic factors [14]. Patients (N =
272) were randomly selected from the COOL (N = 1600), and
their charts assessed by means of the INTERMED. All pa-
tients underwent RYGBP.
Retrospective studies with the INTERMED based on chart
review have already been conducted [15, 16]. Since patients
included in the COOL undergo a comprehensively document-
ed medical and psychiatric assessment, the two investigators
(CZ and YC) who filled in the INTERMED did not encounter
any particular problems. However, for some patients (N = 36),
the social domain score of the INTERMED could not be rated
based on the information available in the charts; these patients
were excluded from the study.
INTERMED: Assessment of Biopsychosocial Case
Complexity
Medical complexity is defined as coexisting conditions, which
hamper the success of medical care [17]. Beside disease- and
treatment-related parameters, psychosocial factors and aspects
situated at the interface between the patient and the health care
system, increase medical complexity. The INTERMED (see
Table 1), an instrument to assess biopsychosocial case com-
plexity, has been demonstrated to identify patients with a di-
minished response to medical treatments [18–20] in many
different patient populations and clinical settings, such as
low back pain [21, 22], chronic shoulder pain [23], diabetes
[24], palliative care [25], or internal medicine [26]. Research
has also shown that early psychosocial interventions targeted
at complex patients identified by means of the INTERMED
improve their outcome [27, 28].
The INTERMED integrates information from four do-
mains—biological, psychological, social, and healthcare
related—assessed in a temporal perspective—history, current
state, and prognosis. The eight domains referring to the past
(history) and present (current state) contain 2 items, and the
four referring to the future (prognosis) contain 1 item. Each
item is scored between 0 and 3, depending on the degree it
contributes to case complexity (higher scores indicating a
higher case complexity). Given that there are 20 items, case
complexity can range from 0 (absence of case complexity) to
60 (highest biopsychosocial case complexity) [19]. Based on
pooled outcomes of INTERMED studies, a cut-off score of
21, which divides patients in non-complex and complex pa-
tients, has been identified [29].
The INTERMED can be used as an observer-rated instru-
ment based on an interview or filled in retrospectively based
on chart reviews. An INTERMED self-assessment, which has
been shown to correlate with the observer-rated version, is
also available [30].
Interrater Reliability Testing with the INTERMED
At the beginning of the study the first 46 charts were double
scored by the two trained INTERMED raters and interrater
reliability (ICC) was calculated. Since the ICC for the
INTERMED sum score was 0.91 indicating a high interrater
reliability, subsequent charts were scored by only one rater
(YC).
Statistical Analyses
Initially, descriptive statistics for BMI and INTERMED
scores were calculated and presented (mean value ± standard
deviation (SD)).
The main analysis was carried out using an individual
growth model (Singer et al, 1998).
For the analysis, we first examined the distribution of pre-
surgical BMI values of the study sample (because baseline
BMI determines the BMI course after surgery). With a mini-
mum baseline BMI of 34.0 and a maximum of 73.4 kg/m2, the
study sample showed a high heterogeneity regarding pre-
surgical BMI. We therefore stratified the sample into BMI
quartiles computed from the individual’s baseline BMI.
Stratum 1 included the 25% of the sample within the lowest
pre-surgical BMI quartile, and stratum 4, respectively, the
25% within the highest pre-surgical BMI quartile.
The prediction of the BMI courses was then modelled for
each quartile separately. For each stratum, we ran four
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regression models (resulting in 16 different regression analy-
ses) to investigate whether the variation in intercepts and
slopes of the individual’s BMI curves was related to an
INTERMED domain score (biological, psychological, social,
or health care use).
For the modelling of the growth curves, we had to consider
that the mean BMI course of the patients is strongly decreas-
ing until 2 years after surgery (Fig. 1). Afterwards, the BMI
course slowly starts to increase. We therefore included in the
growth curve analyses the BMI values of 2–10 years after
surgery.
The conditional growth curve models were fitted as
linear growth models with “time” as fixed effect. The
BMI values measured at 2–10 years after surgery were
entered as repeated measurements. In the regression mod-
el, an INTERMED domain score was included as
covariate—as well as its interaction with time. The param-
eter estimate for the interaction of an INTERMED domain
score with time indicates the differences in growth rates
with respect to the domain score. For a significant time ×
domain score interaction, we finally examined the ex-
plained variation attributable to the domain score by com-
paring the estimates from the unconditional model (with-
out covariate) with the estimates from the conditional
growth model. All analyses were conducted by using
SAS, version 9.4 (SAS Institute Inc., 2017).
Table 1 The INTERMED





Complications and life threat
Psychological Restrictions in coping Resistance to treatment Mental health threat
Premorbid psychiatric dysfunctioning Severity of psychiatric symptoms
Social Restrictions in social integration Residential instability Social vulnerability
Social dysfunctioning Restrictions of social network
Health care Intensity of prior treatment Organizational complexity Care needs
Prior treatment experience Appropriateness
Source: Huyse et al. [18]
Fig. 1 BMI course of the patients
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Results
The baseline characteristics of the selected patients are shown
in Table 2. No significant difference was observed between
selected (N = 236) and excluded patients (N = 36).
Mean pre-surgical (baseline) BMI of included patients (N =
236) was 44.0 ± 5.8 with BMIs ranging from 34.0 to 73.4.
The mean INTERMED total score (20.4 ± 7.3) shows a
significant overall heterogeneity, with scores ranging from 8
to 40, and high biopsychosocial complexity of the sample.
The biological domain (8.7 ± 1.8) shows the highest score,
reflecting the serious health concerns of these patients. The
psychological domain (5.7 ± 2.7) also shows high scores and
psychological heterogeneity.
Based on the high variability in pre-surgical BMI, the study
sample was divided into quartiles. The mean pre-surgical BMI
was 39.2 ± 1.4 in the first quartile, 41.4 ± 0.6 in the second,
43.9 ± 0.9 in the third, and 51.9 ± 5.9 in the fourth quartile.
The biopsychosocial complexity in the four quartiles was
quite similar with mean values of total INTERMED scores
ranging between 19.7 (± 7.1, quartile 3)) and 21.2 (±7.1)
(quartile 4). In Fig. 2a–d, the courses of the patients over 10
years after bariatric surgery are shown, stratified into four
groups according to their baseline BMI.
The courses of the strata indicate that the group with the
lowest baseline BMIs exhibits a relatively homogenous BMI
course over the 10 years after surgery. However, the standard
deviation of BMI courses is increasing over the four groups. In
the fourth stratum with the highest pre-surgical BMI, the BMI
courses after surgery are highly heterogeneous. To quantify
the degree of variation within the four different strata the co-
efficients of variation (CVs)—defined as the ratio of the
respective standard deviation to the mean value—were calcu-
lated for each time point. Figure 3 depicts that at all measure-
ment points, the CV of the fourth quartile was substantially
higher compared to the CVs of quartiles 1–3, reflecting the
greater variability of BMI values in quartile 4.
Growth curve analyses showed that in quartiles 1, 2, and 3,
none of the INTERMED domain scores is a significant pre-
dictor of the BMI course after surgery. However, in the fourth
quartile, the social domain score of the INTERMED signifi-
cantly predicts the course of the 10-year BMI course.
The intercept estimate shows that the average BMI of the
fourth quartile was 32.1 at 2 years after surgery (see Table 3).
The time estimate reflects the average slope of the BMI
course. Hence, the average patient of the fourth quartile began
with a BMI of 32.1 ± 1.12 at 2 years after surgery and gained
0.35 BMI points each year thereafter. The estimate for the
covariate “social domain score” indicates that there is no sig-
nificant relationship between BMI at 2 years after surgery and
the social INTERMED domain (p = 0.36). However, the sig-
nificant parameter estimates of 0.10 for the interaction indi-
cates that persons with a higher score in the INTERMED
social domain have a higher slope in the BMI curve over 10
years after surgery (p = 0.015). A comparison between the
unconditional model and the model including the social do-
main score as covariate shows that the social domain score
explains 9% of the variance in growth rates.
Discussion
This is the first study which uses the INTERMED in a popu-
lation of patients with obesity. The percentage of patients in
Table 2 Baseline characteristics of patients
Included patients (n = 236) Excluded patients (n = 36)
N % n %
Gender
Female 197 83.5 30 83.3
Male 39 16.5 6 16.7
Mean value (SD) [Min;Max] Mean value (SD) [Min;Max]
Age (years) 38.1 (9.5) [20;61] 37.5 (10.3) [19:65]
Pre-OP BMI 44.0 (5.8) [34;73.4] 45.1 (5.2) [39.5:59.2]
BMI (24 months post-OP) 27.4 (4.9) [18.7;50.9] 28.3 (5.2) [21.9;40.5]
BMI (120 months post-OP) (n = 137) 31.8 (7.3) [18.1;63.1] 29.9 (4.4) [22.8;39.2]
INTERMED biological domain 8.7 (1.8) [5;12] 7.7 (1.7) [5;10]
INTERMED psychological domain 5.7 (2.7) [1;12] 5.0 (2.6) [3;8]
INTERMED social domain 2.9 (3.9) [0;13] – –
INTERMED health care use 3.1 (1.7) [1;8] 2.8 (0.8) [2;4]
INTERMED total scores 20.4 (7.3) [8;40] – –
Demographic characteristics of study participants and persons excluded due to missing values
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this sample (42.3%) showing complexity (INTERMED score
≥21) is about one-third higher compared to other samples of
patients with chronic diseases treated in a tertiary care center
[24, 27]. Psychological and social problems in chronic dis-
eases, such as diabetes, rheumatoid arthritis, or low back pain
may be pre-existent or independent of the diseases, a conse-
quence of the disease or simply lacking. In severe obesity, the
psychological, social, and somatic aspects are often interwo-
ven since psychosocial distress may provoke obesity and obe-
sity may provoke psychosocial stress through stigmatization.
Fig. 2 a–d Courses of the patients over 10 years after bariatric surgery are shown
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Fig. 2 (continued)
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Despite the variability of biopsychosocial complexity,
INTERMED scores did not predict courses of BMI after sur-
gery. This result may indicate that the high percentage of
complex patients diminished the predictive power of the
INTERMED. However, it may also be, that “weight loss after
bariatric surgery” is determined by various and yet unknown
factors and thus not comparable with outcomes such as
HbA1c levels [31] or hypertension and hyperlipidemia [32].
Almost all patients show rapid weight loss in the first 2
years after bariatric surgery. The INTERMED scores, if
assessed for example after the second year, may also have
changed compared with baseline, and thus gained in predic-
tive power. What is needed, however, is an outcome predic-
tion instrument that can be used prior to surgery. Moreover,
all except the quartile with the highest baseline BMIs
showed low outcome variation, which may also explain the
limits of the INTERMED regarding outcome prediction. In
the quartile with the highest baseline BMI and the highest
outcome variation, mean biopsychosocial complexity mea-
sured with the INTERMED was not different from the other
quartiles, but the social domain of the INTERMED signifi-
cantly predicted BMI courses over time and explained 9% of
the variance in growth rates. How can we understand these
last results?
It is interesting that heterogeneity regarding surgery out-
comes in obese patients increases, depending on BMI at base-
line. This may be due to different reasons. First, the increased
possible amount of total weight loss in patients who have very
high BMI scores increases the possibility of variance with
regard to outcomes [33]. Second, more severe eating disorder,
associated with psychiatric comorbidities, may hamper favor-
able long-term outcome and favor weight regain [34–37].
Third, surgery can have both negative and positive effects,
which is difficult to predict, as it also requires psychological
adaptation to a modified body.
While these reasons may explain outcome variability, the
fact remains that 9% of the variance in growth rates can be
explained by the social domain of the INTERMED at base-
line. The higher the social problems at baseline, the more
patients from the fourth quartile increase in BMI in the course
of 2–10 years after surgery. The explanation is likely to be
multifactorial. Patients suffering from severe obesity, more
stigmatized by the social environment, have more difficulties
to remain mobile and socially active and more often lose their
work [38]. In addition, considering the important psychosocial
stress and high psychiatric morbidity associated with obesity
[39], the sole buffer for coping with obesity might be social
support. Social support not only beneficially influence psychi-
atric morbidity and eating disorders after bariatric surgery [40]
but is also a decisive factor for greater weight loss after sur-
gery, and social support plays an important role with regard to
treatment adherence [41] and motivation for change [42].
Social problems are also associated with chronic stress and
higher cortisol levels, which can promote long-term weight
regain [43]; moreover, patients with low socio-economic sta-
tus are physically less active [44].
Finally, the observation that the mean social domain
score in the quartile with the highest BMI baseline scores
was similar to the mean social domain score in the quartile
with the lowest BMI baseline score is a last interesting
result. We hypothesize that the social domain score only
plays a role in groups with higher outcome heterogeneity,
thanks to the buffering effect of “the social” (social sup-
port, social network, social isolation). Alfa Wali et al. have
studied the impact of socio-economic deprivation on bar-
iatric weight loss outcomes and demonstrated that there
Fig. 3 CV of quartiles 1 to 4
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was no significant difference in outcomes, according to
deprivation level up to 2 years after surgical intervention,
which is in line with our results for this follow-up time
[45].
To summarize: the INTERMED failed to predict weight
loss after RYGB, for the reasons mentioned above, but this
study reveals a clinically relevant and sometimes neglected
aspect of obesity care, the social difficulties associated with
obesity. While psychiatric evaluation and treatment is an in-
tegral part of obesity care, a systematic assessment of the
social situation by social workers is lacking in many centers,
as it is the case in ours. At least in our center, social workers
are only included in the treatment, when the endocrinologist,
surgeon or psychologist/psychiatrist refer the patient. Our
study indicates, however, that availability and easy access to
social assessment, counselling, and help should probably be
part of obesity treatment since it might improve results.
Our study has methodological strengths, such as the long-
term follow-up and having used all the available BMI mea-
surements over time (by modelling growth rates). This
allowed to observe that BMI courses differ widely depending
on pre-surgical BMI and that social factors might play a deci-
sive role in the very obese with the highest outcome variance.
A limitation of the study is its retrospective character and
its sample size. However, retrospective studies based on chart
review have already been conducted with the INTERMED
and interrater-reliability of the INTERMED assessments was
very high. Given the sample size, a replication of the prognos-
tic value of the INTERMED social score in a larger sample
would be useful.
Conclusion
Our study showed that outcome in terms of weight loss among
patients with more-severe obesity (quartile 4) undergoing
RYGB differ more in long-term BMI course compared with
patients suffering from less-severe obesity (quartiles 1, 2, and
3). Despite a wide heterogeneity of the quartile 4 population,
the social domain of the INTERMED explained 9% of vari-
ability of the long-term post-operative weight at 10 years.
Interventions aiming the assessment of, and support in the
social dimensions for patients with very severe obesity, should
therefore be evaluated in future studies, since they might in-
fluence weight outcome. Further studies will have to prove if
early social interventions, complementing psychiatric care for
those who are in need, will be beneficial.
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